Tratamiento de adicciones en Colombia

Naciones Unidas, 2009 Colombia, Ministerio de la Protección Social, Fundación FES Social. Segundo Estudio Nacional de Salud Mental – 2003. Bogotá: Ministerio de la Protección Social. Colombia, Ministerio de la Protección Social, 2009 Colombia, Dirección Nacional de Estupefacientes, 1992 Colombia, Dirección Nacional de Estupefacientes -DNE-, 1996 Colombia, Presidencia de la República, 2002 Colombia, Ministerio de la Protección Social, 2004 Rush, 2008, Prevalence and profile of people with co-ocurring mental and substance use disorders within a comprehensive mental health system, Can J Psychiatry, 53, 810, 10.1177/070674370805301207 Rao, 2009, Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: interactions between stress and HPA activity, Am J Psychiatry, 166, 361, 10.1176/appi.ajp.2008.08030412 Fidalgo, 2008, Psychiatric comorbidity related to alcohol use among adolescents, Am J Drug Alcohol Abuse, 34, 83, 10.1080/00952990701764664 Arendt, 2005, Cannabis induced psychosis and subsequent schizophrenia spectrum disorders: follow-up study of 535 incident cases, Br J Psychiatry, 187, 510, 10.1192/bjp.187.6.510 Arsenault, 2004, Causal association between cannabis and psychosis: examination of the evidence, Br J Psychiatry, 184, 110, 10.1192/bjp.184.2.110 Henquet, 2005, Prospective cohort study of cannabis use, predisposition for psychosis and psychotic symptoms in young people, BMJ, 330, 11, 10.1136/bmj.38267.664086.63 Zammit, 2002, Self reported cannabis use as risk factor for schizopherenia in Swedish conscripts of 1969. historical cohort study, BMJ, 325, 1199, 10.1136/bmj.325.7374.1199 Ferguson, 2003, Cannabis dependence and psychotic symptoms in young people, Psychol Med, 33, 15, 10.1017/S0033291702006402 Brook, 2001, The effect of early marijuana use on later anxiety and depressive symptoms, NYS Psychologist, 35 Patton, 2002, Cannabis use and mental health in young people: cohort study, BMJ, 325, 1195, 10.1136/bmj.325.7374.1195 Moore, 2007, Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review, Lancet, 370, 319, 10.1016/S0140-6736(07)61162-3 Witkin, 2005, A role for cannabinoid CB1 receptors in mood and anxiety disorders, Behav Pharmacol, 16, 315, 10.1097/00008877-200509000-00005 Kupka, 2005, Comparison of rapid – cycling and non – rapid – cycling bipolar disorder based on prospective mood ratings in 539 outpatients, Am J Psychiatry, 162, 1273, 10.1176/appi.ajp.162.7.1273 Cassidy, 2001, Substance abuse in bipolar disorder, Bipolar Disord, 3, 181, 10.1034/j.1399-5618.2001.30403.x McElroy, 2001, Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder, Am J Psychiatry, 158, 420, 10.1176/appi.ajp.158.3.420 Casas, 2008, Trastorno bipolar asociado al uso de sustancias adictivas (patología dual). Revisión sistemática de la evidencia científica y consenso entre profesionales expertos, Actas Esp Psiquiatr, 36, 350 Brown, 2005, Bipolar disorder and substance abuse, Psychiatr Clin North Am, 28, 415, 10.1016/j.psc.2005.01.004 Weiss, 2005, Does recovery from substance use disorder matter in patients with bipolar Disorder?, J Clin Psychiatry, 66, 730, 10.4088/JCP.v66n0609 Baethge, 2005, Substance abuse in first episode bipolar I disorder: indication for early intervention, Am J Psychiatry, 162, 1008, 10.1176/appi.ajp.162.5.1008 Hasin, 2006, Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV, Am J Psychiatry, 163, 689, 10.1176/ajp.2006.163.4.689 Kruedelbach, 2006, Comorbilidad de trastornos con pérdida de control de impulsos: ludopatía, adicciones y trastornos de personalidad, Actas Esp Psiquiatr, 34, 76 Brown, 2005, Switching out patients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole, J Clin Psychiatry, 66, 756, 10.4088/JCP.v66n0613 Desai, 2005, Identificación sistemática de los trastornos por consumo de alcohol en pacientes extra hospitalarios con enfermedades medicas: importancia de las características del individuo y de los servicios asistenciales, Am J Psychiatry, 162, 1521, 10.1176/appi.ajp.162.8.1521 Souza, 2008, Nosografía y manejo de la patología asociada al consumo de cocaína, Rev Mex Neurociencia, 9, 141 2004, The effects of alcohol on physiological development, Alcohol Res Health, 28, 125 Gual Antoni. Alcohol. Adicciones. 2002;14 Suplemento. Fernández, 2005, Opiáceos, Adicciones, 17 Suplemento 2, 1 Pereiro Gómez, 2006, Patología orgánica en adicciones, Adicciones, 18 Suplemento 1, 1 López, 2002 World Health Organization, 1992 Kanno, 2002, Sexually transmitted diseases in injection drugs users, Infect Dis Clin North Am, 16, 771, 10.1016/S0891-5520(02)00011-9 de los Cobos Peris, 2006, Capitulo 9: Tratado Set de trastornos adictivos, 399 Carroll, 2005, Behavioral therapies for drug abuse, Am J Psychiatry, 162, 1452, 10.1176/appi.ajp.162.8.1452 Dutra, 2008, A Meta-analytic review of psychosocial interventions for substance use disorders, Am J Psychiatry, 165, 179, 10.1176/appi.ajp.2007.06111851 American Psychiatric Association. Guía clínica para el tratamiento de los trastornos por abuso de sustancias, alcohol, cocaína, opiáceos. Ars Médica. 2004. Casas, 2004 Brown, 2006, Naltrexone in patients with bipolar disorder and alcohol dependence, Depress Anxiety, 23, 492, 10.1002/da.20213 Campos, 2005, Situación actual de los programas de desintoxicación ¿cuándo y cómo desintoxicar?, Adicciones: Revista de socidrogalcohol, 17, 205 Salloum, 2007, Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study, Addict Behav, 32, 410, 10.1016/j.addbeh.2006.05.007 Klingemann, 1999, National treatment systems in global perspective, Eur Addict Res, 5, 109, 10.1159/000018978 Vocci, 2005, Medication development for addictive disorders: the state of the science, Am J Psychiatry, 162, 1432, 10.1176/appi.ajp.162.8.1432 Schuckit, 2009, Alcohol use disorders, Lancet, 373, 492, 10.1016/S0140-6736(09)60009-X Blasco, 2006, Tratamiento Integrado de los Trastornos Adictivos, 459 Sadock, 2007, Substance related disorders, 381 de las Cuevas Castresana, 2006, Clínica y tratamiento de la adicción a las benzodiacepinas, 217 Reid, 2009, Valproate treatment and cocaine cue reactivity in cocaine dependent individuals, Drug and alcohol dependence, 102, 144, 10.1016/j.drugalcdep.2009.02.010 Johnson, 2003, Oral topiramate for treatment of alcohol dependence: a randomised controlled trial, Lancet, 361, 1677, 10.1016/S0140-6736(03)13370-3 Anderson, 2009, Modafinil for the treatment of cocaine dependence, Drug Alcohol Depend, 104, 133, 10.1016/j.drugalcdep.2009.04.015 Souza, 2004, Adicciones, psicopatología y psicoterapia, Rev Mex Neuroci, 5, 57 Mata, 2005, Estructuras familiares y comportamientos adictivos, Rev Arg Clín Neuropsiquiatr, 12, 32 García, 2002, Patología familiar y violencia domestica, Adicciones: revista de socidrogalcohol, 14, 221 Moyer, 2002, Brief Interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and no treatment-seeking populations, Addiction, 97, 279, 10.1046/j.1360-0443.2002.00018.x Anderson, 2003, Attitudes and management of alcohol problems in general practice: descriptive analysis based on findings of a Word Health Organization International collaborative survey, Alcohol Alcohol, 38, 597, 10.1093/alcalc/agg119 Oficina de las Naciones Unidas contra la droga y el delito, 2003 Comisión Interamericana para el Control del Abuso de Drogas, 1999 National Institute on Drug Abuse, 1999 O'Brien, 2005, Anticraving medications for relapse prevention: a possible new class of psychoactive medications, Am J Psychiatry, 162, 1423, 10.1176/appi.ajp.162.8.1423 Mejía, 2004 Stern, 2004 Fiellin, 2000, Screening for alcohol problems in primary care a sistematic review, Arch Intern Med, 160, 1977, 10.1001/archinte.160.13.1977 Rosta, 2008, Alcohol use among hospital doctors in Germany, Alcohol Alcohol, 43, 198, 10.1093/alcalc/agm180 Desai, 2005, Screening for alcohol use disorders among medicals outpatients: the influence of individual and facility characteristics, Am J Psychiatry, 162, 1521, 10.1176/appi.ajp.162.8.1521 Babor, 2001 Charbonney, 2010, Alcohol, drugs and trauma consequences, screening and intervention in 2009, Trauma, 12, 5, 10.1177/1460408609349888 Gentillello, 2005, Alcohol intervention for trauma patients treated in emergency departments and hospitals a cost benefit analysis, Ann Surg, 241, 541, 10.1097/01.sla.0000157133.80396.1c Spirito, 2004, A randomized clinical trial of brief motivational intervention for alcohol-positive adolescents treated in an emergency Department, J Pediatr, 145, 396, 10.1016/j.jpeds.2004.04.057 Vasilaki, 2006, The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review, Alcohol Alcohol, 41, 328, 10.1093/alcalc/agl016 Stewart, 2008, Personalized feedback on alcohol problems in young adults is more effective as part of motivational interview, Evidence-Mental Health, 11, 51, 10.1136/ebmh.11.2.51 Kinght, 2005, Motivational interviewing for adolescent substance use: a pilot study, J Adolesc Health, 37, 167, 10.1016/j.jadohealth.2004.08.020 Green, 2004, Gender differences in outcomes in an HMO based substance abuse treatment program, J Addict Dis, 23, 47, 10.1300/J069v23n02_04 Hien, 2004, Promising treatments for women with comorbid PTSD and substance use disorders, Am J Psychiatry, 161, 1426, 10.1176/appi.ajp.161.8.1426 Kaskutas, 2005, Women's programs versus mixed-gender day treatment: results from a randomized study, Addiction, 100, 60, 10.1111/j.1360-0443.2005.00914.x Koetzle, 2009, Drug abusing women in the community: the impact of drug court involvement on recidivism, Journal of Drug Issues, 39, 803, 10.1177/002204260903900402 Nuño-Gutierrez, 2006, La adicción vicio o enfermedad imágenes y usi de servicios de salud en adolescentes, usuarios y sus padres, Salud Mental, 29, 47 Junta Internacional de Fiscalización de Estupefacientes JIFE, 2010 Fernández, 2001, Influencia de los trastornos psiquiátricos en la efectividad de un programa de mantenimiento prolongado con metadona, Actas españolas de psiquiatría, 29, 228 Soyka, 2008, Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study, Int J Neuropsychopharmacol, 11, 641, 10.1017/S146114570700836X Mattick, 2009, Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database Syst Rev, 8, 10.1002/14651858.CD002209.pub2